secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2026-08-04T20:03:07+00:00
Accession:  0001193125-26-332742
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics terminates Cambridge lease early, reduces facilities costs
-----------------------------------------------------------------------------

- Surrenders 21,295 sq ft immediately; remaining 47,341 sq ft vacated by Dec 31, 2026 (original lease end Jan 13, 2031).
- Total consideration: $2.2M LC increase, $3.85M termination fee, and 103,520 shares of stock valued at $500k.
- Lease termination eliminates primary restoration obligations and reduces ongoing annual facilities costs.
- Stock issued at $4.83 per share, registered on Form S-3, freely tradeable upon issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312526332742/0001193125-26-332742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312526332742/d133274d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-332742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer